Remove bottlenecks with automated analytical methods
As a rapidly expanding industry, cell and gene therapy products are poised to become an established field in providing innovative and personalized therapeutics. However, several bottlenecks continue to impinge on the research, development and manufacturing of viral vector-based cell and gene therapeutics, resulting in delayed time to market. In this eBook, platforms are explored that provide rapid method development for cell and gene therapy immunoasays, including an investigation into the role of automation. You will learn more about Gyrolab® miniaturized immunoassay technology as a method of automation to generate data comparable to ELISA with less hands-on time, lower consumption of reagents and samples and minimized matrix interference.
Find out why Krya Therapeutics , NC, US decided to implement the Gyrolab platform in their lab and what benefits they see using its platform:
Read the full 60sek interview with Gabe Fawcett by downloading the eBook